Ultimovacs ASA: Invitation to fourth quarter 2022 results webcast presentation

09 Feb 2023 08:00 CET

Oslo, 9 February 2023: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-
stage biotechnology leader in novel immunotherapeutic cancer vaccines, invites
to a webcast presentation of its fourth quarter 2022 results on Thursday 16
February 2023.

The presentation can be followed as a live webcast accessed through a link on
www.ultimovacs.com at 14:00 CET on Thursday 16 February 2023. The webcast
presentation will be available on the Ultimovacs website, and it will be
possible to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 08:00
CET the same day.

For further information, please see www.ultimovacs.com or contact:

Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507

Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632

Anne Worsøe, Head of IR & Communication
Email: anne.worsoe@ultimovacs.com
Phone: +47 906 86815

More information:
Access the news on Oslo Bors NewsWeb site